In contrast with these findings in CIML-NK cells but in line with the previous findings reported by the Fiedler group [31], we observed a clear effect of TIGIT-blockade when testing the cytotoxicity of the NK-92 cells toward the AML cell lines Molm-13 and HL-60. The gene discussed is TIGIT; the disease is acute myeloid leukemia.